Bentham Science Logo

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 15, 4 Issues, 2020
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Ranking and Category

  • 173rd of 229 in

    Oncology

  • 171st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 14

-

Number 4



Biography   Open Access



Commentary   Open Access



Review Article



Review Article



Review Article



Research Article



Patent Selections   Open Access



Acknowledgement   Open Access



Articles Ahead of Print

Increased NID1 Expression among Breast Cancer Lung Metastatic Women; A Comparative Analysis between Naive and Treated Cases


Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Ghulam Haider, Syed Nudrat Nawaid Shah, Rubina Ghani and Muhammad Fazal Hussain Qureshi


DOI: 10.2174/1574892815666200302115438
View Abstract View on PubMed








Abstracts Ahead of Print

The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX


Ijaz Muhammad, Noor Rahman, Gul E Nayab, Sadaf Niaz, Mohibullah Shah, Sahib Gul Afridi, Haroon Khan*, Maria Daglia and Esra Capanoglu


DOI: 10.2174/1574892815666200226112506
View Abstract


Published Contents

Editor's Choice


HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*


DOI: 10.2174/1574892812666170619125503



Open Access Articles


From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*


DOI: 10.2174/1574892814666190514104035


Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023



Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*


DOI: 10.2174/1574892814666190111104834


Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848


Review Article

Purinergic P2X7 receptor: A cation channel sensitive to tumor microenvironment

, 2019; 14(1): 32-38.

Giorgia Scarpellino, Tullio Genova and Luca Munaron*


DOI: 10.2174/1574892814666190116122256


Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157


General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001





Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna


DOI: 10.2174/1574892814666191022163540





Most Accessed Articles

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211





Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer

, 2019; 14(3): 226-241.

Emanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, Giulia Fornasier, Elisa Giacomin, Francesco Lo Re, Paolo Baldo*, Giuseppe Corona and Carlo Gobitti


DOI: 10.2174/1574892814666190726143011


HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001


Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer

, 2019; 14(3): 242-257.

Alessandra Bearz, Sara Cecco, Sara Francescon, Francesco Lo Re, Giuseppe Corona and Paolo Baldo*


DOI: 10.2174/1574892814666190726124735



Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma

, 2019; 14(3): 203-225.

Debora Basile, Camilla Lisanti, Maria A. Pizzichetta, Paolo Baldo*, Giulia Fornasier, Francesco Lo Re, Giuseppe Corona and Fabio Puglisi


DOI: 10.2174/1574892814666190726130351




Related Journals

Related eBooks

eBooks Catalog